首页 | 产品信息 | 技术研发 | 常规服务 | 订单下载 | 访客留言 | 联系我们  
 产品分类 
· 蛋白相关
·重组蛋白;
·蛋白提取试剂盒;
·蛋白定量试剂盒;
·蛋白纯化试剂;
·细胞培养添加蛋白因子;
·蛋白Marker
· 核酸相关
·吸附柱法核酸提取试剂盒;
·磁珠法核酸提取试剂盒
·免核酸提取样品保存液/核酸释放剂;
·核酸采集与保护套装;
·一次性病毒采样管套装;
·一步法新型冠状病毒荧光定量PCR试剂盒
·表达质粒
·一次性核酸胶体金试纸条
· 试剂盒相关
·ELISA 试剂盒;
·细胞凋亡检测试剂盒;
·细胞转染试剂;
·ECL高灵敏度化学发光试剂盒
· 抗体相关
·一抗;
·二抗;
·体外诊断(IVD)活性抗体;
·抗体纯化试剂
· CDMO服务
·细胞株开发;
·细胞培养工艺开发;
·蛋白纯化工艺开发;
·制剂工艺开发;
·中试放大生产;
·GMP生产服务
· 其他
·核酸清除剂
·灭菌注射用水
·荧光染料
 技术研发分类 
· 蛋白定制服务
· 抗体定制服务
· 试剂盒定制服务
· 课题项目服务
 常规服务分类 
· IF及IHC技术服务
· Western blot服务
· 蛋白纯化及标记服务
· 实时荧光定量PCR
产品信息 >> 蛋白相关 >> 重组蛋白;
Recombinant Human p16-INK4a-TAT

产品描述

概述

Cyclin-dependent kinase inhibitors (CDKIs) are proteins that bind to and inhibit the activity of CDKs. Two major classes of CDK inhibitors have been identified. The p16 family (p15, p16, p18 and p19) binds to and inhibits the activities of CDK4 and CDK6. The p21 family (p21, p27, p28 and p57) can bind to broad range of CDK-cyclin complexes and inhibit their activities. CDKIs are capable of suppressing growth, and several lines of evidence strongly suggest that at least some CDKIs may be tumor suppressor proteins. p16-INK4A is the member of p16 family and is encoded by CDKN2A gene in humans. It has three isoforms, which are wildly expressed but not detected in brain or skeletal muscle, except that isoform 3 is pancreas-specific. Defects in p16INK4A are a cause of Li-Fraumeni syndrome (LFS) and melanoma-astrocytoma syndrome (MASTS). The TAT transduction peptide can help rHuP16-INK4a with acrossing all kind of biomembranes in vivo and has no effect on the super structure of the protein.

使用说明

This material is offered by Novin Biotech for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE.

技术规格

Physical AppearanceSterile Filtered White lyophilized (freeze-dried) powder.
Purity> 95 % by SDS-PAGE and HPLC analyses.
SourceEscherichia coli.
Biological ActivityData is not available.
FormulationLyophilized from a 0.2 μm filtered concentrated solution in 2 × PBS, pH 7.0.
EndotoxinLess than 1 EU/μg of rHuP16-INK4a-TAT as determined by LAL method.
ReconstitutionWe recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
AA SequenceEPAAGSSMEP SADWLATAAA RGRVEEVRAL LEAGALPNAP NSYGRRPIQV MMMGSARVAE LLLLHGAEPN CADPATLTRP VHDAAREGFL DTLVVLHRAG ARLDVRDAWG RLPVDLAEEL GHRDVARYLR AAAGGTRGSN HARIDAAEGP SDIPDGYGRK KRRQRRR
上一篇:Recombinant Human Rb    下一篇:Recombinant Murine C
关于我们   |   诚聘英才   |   信息发布   |   新品推荐   |   技术支持

     电话:400-832-8698    地址:北京怀柔雁栖开发区光织谷东区二号楼 

   备案/许可证编号京ICP备2020036913号

京ICP备2020036913号    技术支持:华大网络